Kezar Life Sciences Inc
$ 7.33
-0.54%
17 Apr - close price
- Market Cap 54,033,000 USD
- Current Price $ 7.33
- High / Low $ 7.39 / 7.33
- Stock P/E N/A
- Book Value 9.56
- EPS -7.66
- Next Earning Report 2026-05-12
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.30 %
- ROE -0.60 %
- 52 Week High 7.55
- 52 Week Low 3.53
About
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, is dedicated to the discovery and development of new small molecule therapies to address the unmet needs in immune-mediated diseases and cancer in the United States. The company is headquartered in South San Francisco, California.
Analyst Target Price
$6.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-30 | 2025-11-12 | 2025-08-13 | 2025-06-18 | 2025-03-12 | 2024-11-13 | 2024-08-13 | 2024-05-09 | 2024-03-14 | 2023-11-13 | 2023-08-10 | 2023-05-11 |
| Reported EPS | -1.0536 | -1.53 | -1.87 | -2 | -3 | -2.78 | -0.27 | -0.3 | -0.44 | -0.32 | -0.34 | -0.31 |
| Estimated EPS | -1.31 | -0.26 | -0.28 | -2.65 | -2.76 | -3.15 | -0.32 | -0.33 | -0.38 | -0.35 | -0.32 | -0.29 |
| Surprise | 0.2564 | -1.27 | -1.59 | 0.65 | -0.24 | 0.37 | 0.05 | 0.03 | -0.06 | 0.03 | -0.02 | -0.02 |
| Surprise Percentage | 19.5725% | -488.4615% | -567.8571% | 24.5283% | -8.6957% | 11.746% | 15.625% | 9.0909% | -15.7895% | 8.5714% | -6.25% | -6.8966% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-12 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.98 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
